Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong · Delayed Price · Currency is HKD 81.20
-0.70 (-0.85%)
Sep 10, 2026, 4:08 PM HKT
Vigonvita Life Sciences Market Cap
Vigonvita Life Sciences has a market cap or net worth of 13.61 billion as of September 10, 2026.
Market Cap
13.61B
Enterprise Value
14.12B
Revenue
250.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
81.20
ChartMarket Cap Chart
Since November 6, 2025, Vigonvita Life Sciences's market cap has decreased from 13.74B to 13.61B, a decrease of -0.98%. That is a compound annual growth rate of -1.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 13.61B | -0.79% |
| Dec 31, 2025 | 13.72B | -0.18% |
| Nov 6, 2025 | 13.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 319.41B |
| Hansoh Pharmaceutical Group Company | 219.96B |
| WuXi Biologics | 202.31B |
| Innovent Biologics | 176.36B |
| Duality Biotherapeutics | 16.88B |
| The United Laboratories International Holdings | 16.60B |
| Angelalign Technology | 16.20B |
| Fujian Haixi Pharmaceuticals | 15.48B |